INNOVATIVE EXTRACORPOREAL TECHNOLOGIES


Cite item

Full Text

Open Access Open Access
Restricted Access Access granted
Restricted Access Subscription or Fee Access

Abstract

The paper presents the classification of extracorporeal techniques according to their level of selectivity. Current selective and specific extracorporeal technologies are characterized; their advantages and disadvantages are described. Selective and specific extracorporeal technologies can be designed if it is precisely known that target-removed molecules or blood cells play a key role in the pathogenesis of the disease. Their introduction is reasonable if it leads to the increased efficiency and safety of extracorporeal treatment.

Full Text

Restricted Access

About the authors

A. Sokolov

I.I. Mechnikov North-Western State Medical University

Email: dr.sokolov@list.ru
Professor

References

  1. Соколов А.А. Современные экстракорпоральные технологии: каскадная плазмофильтрация / СПб, 2013; 60 с.
  2. van Buuren F., Kreickmann S., Horstkotte D. et al. HELP apheresis in hypercholesterolemia and cardiovascular disease: efficacy and adverse events after 8,500 procedures // Clin. Res. Cardiol. Suppl. - 2012; 7: 24-30.
  3. Hirata N., Kuriyama T., Yamawaki N. Immusorba TR and PH // Ther. Apher. Dial. - 2003; 7 (1): 85-90.
  4. Wu F., Heng K., Salleh R. et al. Comparing peripheral blood stem cell collection using the COBE Spectra, Haemonetics MCS+, and Baxter Amicus // Transfus. Apher. Sci. - 2012; 47 (3): 345-50.
  5. Cancelas J., Padmanabhan A., Le T. et al. Spectra Optia granulocyte apheresis collections result in higher collection efficiency of viable, functional neutrophils in a randomized, crossover, multicenter trial // Transfusion. - 2015; 55 (4): 748-55.
  6. Leitner G., Worel N., Vogelsang H. Selective Granulocyte and Monocyte Apheresis as a Non-Pharmacological Option for Patients with Inflammatory Bowel Disease // Transfus. Med. Hemother. - 2012; 39 (4): 246-52.
  7. Афанасьева О.И., Алтынова Е.В., Соколов А.А. и др. Сравнительный анализ эффективности и специфичности разных сорбентов для афереза липопротеидов низкой плотности // Бюлл. эксперимент. биол. и медицины. -2006; 142 (11): 532-7.
  8. Rönspeck W., Brinckmann R., Egner R. et al. Peptide based adsorbers for therapeutic immunoadsorption // Ther. Apher. Dial. - 2003; 7 (1): 91-7.
  9. Mock U., Nickolay L., Philip B. et al. Automated manufacturing of chimeric antigen receptor T cells for adoptive immunotherapy using CliniMACS prodigy // Cytotherapy. - 2016; 18 (8): 1002-11.
  10. Poullin P., Announ N., Mugnier B. et al. Protein A-immunoadsorption (Prosorba column) in the treatment of rheumatoid arthritis // Joint Bone Spine. -2005; 72 (2): 101-3.
  11. Мануилов А.С., Бардаков С.Н., Соколов А.А. и др. Сравнительная оценка динамики концентрации иммуноглобулинов при каскадной плазмофильтрации и иммуносорбции с регенерацией сорбционных колонок. Лечебный гемаферез и экстракорпоральная гемокоррекция: достижения и надежды. -Тезисы докл. III Конф. национальн. общ. спец. в обл. гемафереза и экстракорп. гемокор. СПб, 2017; с. 60-1.

Supplementary files

Supplementary Files
Action
1. JATS XML

Copyright (c) 2022 Russkiy Vrach Publishing House

This website uses cookies

You consent to our cookies if you continue to use our website.

About Cookies